1 / 80

Egypt Connected Healthcare Market Analysis Sample Report

Egypt's connected healthcare market is projected to grow from $185.81 Mn in 2022 to $1506.39 Mn by 2030, registering a CAGR of 29.9% during the forecast period of 2022-30. The main factors driving the growth would be increased adoption of digital technology, rising demand for healthcare services, improving internet penetration and government support. The market is segmented by type, function and by application.<br>To get a detailed report, contact us at - info@insights10.com

Insights4
Download Presentation

Egypt Connected Healthcare Market Analysis Sample Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. A sample report on Egypt Connected Healthcare Market Includes Market Size, Market Segmented by Types and Key Competitors (Data forecasts from 2022 – 2030F) www.insights10.com

  2. This report presents a strategic analysis of the Egypt Connected Healthcare Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Egypt Connected Healthcare Market, and offers unmatched value, accuracy, and expert insights

  3. Report Scope Report Attribute Details Number of Pages 70-80 Base Year for Estimation 2022 Forecast Period 2023-2030 Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario Report Coverage Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Research Approach Secondary Research (60%), Primary Research (40%) Click on the icon to know the detailed methodology 3 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  4. Table of Content CONTENT PG. NO. 12-25 1. Egypt Connected Healthcare Overview 1.1. Overview 1.2. Egypt Overview 1.3. Economic Overview: Egypt 1.4. Connected Healthcare Market in Egypt 1.5. Healthcare Market in Egypt 1.6. Healthcare Scenario in Egypt 1.7. Health Insurance Coverage: Egypt 1.8. Budget of the Government for Public Insurance 1.9. Mergers and Acquisitions 26-31 2. Market Size and Forecasting 2.1 Market size and forecasts (Excel and Methodology) 4 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  5. Table of Content CONTENT PG. NO. 2.2. Market Segmentation 2.2.1. By Type 2.2.2. By Function Type 2.2.3. By Application Type 32-35 3. Market Dynamics 3.1. Market Growth Drivers 3.1.1. Egypt Connected Healthcare Market Analysis Driver 1 3.1.2. Egypt Connected Healthcare Market Analysis Driver 2 3.1.3. Egypt Connected Healthcare Market Analysis Driver 3 3.2. Market Restraints 3.2.1. Egypt Connected Healthcare Market Analysis Restraint 1 3.2.2. Egypt Connected Healthcare Market Analysis Restraint 2 5 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  6. Table of Content CONTENT PG. NO. 3.2.3. Egypt Connected Healthcare Market Analysis Restraint 3 36-46 4. Competitive Landscape 4.1. Major Market Share 4.2. Key Company Profile 4.2.1. 7Keema 4.2.1.1. Overview 4.2.1.2. Product Applications & Services 4.2.1.3. Recent Developments 4.2.1.4. Partnerships Ecosystem 4.2.1.5. Financials (Based on Availability) 4.2.2. Tabibi 24/7 4.2.2.1. Overview 6 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  7. Table of Content CONTENT PG. NO. 4.2.2.2. Product Applications & Services 4.2.2.3. Recent Developments 4.2.2.4. Partnerships Ecosystem 4.2.2.5. Financials (Based on Availability) 4.2.3. 3elagi 4.2.3.1. Overview 4.2.3.2. Product Applications & Services 4.2.3.3. Recent Developments 4.2.3.4. Partnerships Ecosystem 4.2.3.5. Financials (Based on Availability) 4.2.4. Siemens Healthineers 4.2.4.1. Overview 7 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  8. Table of Content CONTENT PG. NO. 4.2.4.2. Product Applications & Services 4.2.4.3. Recent Developments 4.2.4.4. Partnerships Ecosystem 4.2.4.5. Financials (Based on Availability) 4.2.5. Allscripts Healthcare 4.2.5.1. Overview 4.2.5.2. Product Applications & Services 4.2.5.3. Recent Developments 4.2.5.4. Partnerships Ecosystem 4.2.5.5. Financials (Based on Availability) 4.2.6. Apple 4.2.6.1. Overview 8 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  9. Table of Content CONTENT PG. NO. 4.2.6.2. Product Applications & Services 4.2.6.3. Recent Developments 4.2.6.4. Partnerships Ecosystem 4.2.6.5. Financials (Based on Availability) 4.2.7. Microsoft 4.2.7.1. Overview 4.2.7.2. Product Applications & Services 4.2.7.3. Recent Developments 4.2.7.4. Partnerships Ecosystem 4.2.7.5. Financials (Based on Availability) 4.2.8. Fitbit 4.2.8.1. Overview 9 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  10. Table of Content CONTENT PG. NO. 4.2.8.2. Product Applications & Services 4.2.8.3. Recent Developments 4.2.8.4. Partnerships Ecosystem 4.2.8.5. Financials (Based on Availability) 4.2.9. McKesson 4.2.9.1. Overview 4.2.9.2. Product Applications & Services 4.2.9.3. Recent Developments 4.2.9.4. Partnerships Ecosystem 4.2.9.5. Financials (Based on Availability) 4.2.10. NXGN Management 4.2.10.1. Overview 10 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  11. Table of Content CONTENT PG. NO. 4.2.10.2. Product Applications & Services 4.2.10.3. Recent Developments 4.2.10.4. Partnerships Ecosystem 4.2.10.5. Financials (Based on Availability) 47-52 5. Reimbursement Scenario 5.1. Reimbursement Regulation 5.2. Reimbursement Process for Diagnosis 5.3. Reimbursement Process for Treatment 53 6. Methodology & Scope 11 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  12. Egypt Connected Healthcare Market Analysis 1. Connected Healthcare Overview

  13. 1.1 Statistics at a Glance: The Scenario of Connected Healthcare in the World Scenario of Connected Healthcare Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ $58.2 Bn the market for connected healthcare was in 2022 $520.6 Bn it is expected that the market for Global connected healthcare would grow by 2032 In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic ▪ 22% The connected healthcare industry is expected to be dominated by telehealth, with a CAGR of over 22% from 2021 to 2028 $27.20 Bn The North American region dominated the global market in 2021, with a market size of $27.20 Bn dollars, because of increased healthcare costs and a growing demand for connected healthcare products In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 13 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  14. 1.1 Statistics at a Glance: The Burden of Connected Healthcare in the World (continued) Europe ~Revenue to reach $xx Bn by 2027 North America ~ Market Size of $xx Bn Asia -Fastest CAGR Africa Egypt Market ~$xx Market ~Market Size of $xx Illustrative Illustrative 14 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  15. 1.2 Egypt Overview Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ 109.34 Mn Is the population of Egypt, in 2022 404.14 Bn Is the Gross Domestic Product (GDP) in Egypt in 2022 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 24.6 Is the median age in Egypt, in 2023 $6.84 k per capita was the amount of national health expenditures in 2021 15 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  16. 1.3 Economic Overview: Egypt Population of Egypt, (2020-2030) GDP of Egypt, (2020-2030) XX XX XX XX 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F Population Split (2023) In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ By Gender By Age Group In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 0-14 15-24 25-54 Male 49% Female 51% Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 55-64 65+ Illustrative Illustrative 16 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  17. 1.4 Statistics at a Glance: The Scenario of Connected Healthcare in Egypt Scope of Connected Healthcare Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ $192.68 Mn the connected healthcare market in Egypt had been calculated in 2023 $1758.79 is expected market size of the connected healthcare market in Egypt by 2035 In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic in Egypt ▪ 32.68% By 2035, it is expected that the healthcare sector in Egypt would develop at an average yearly rate of growth of 32.68% +70% of fatalities in Egypt in 2022 would be brought on by chronic diseases including diabetes, heart disease, cancer, etc In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 17 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  18. 1.5 Healthcare in Egypt Egypt Healthcare Market Forecast, 2022-2030 (in $Bn) xx xx xx xx xx xx xx xx xx 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the overall Healthcare market in Egypt, which includes the market size, current trends and other details related to the topic ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 18 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  19. 1.6 Healthcare Scenario in Egypt Cancer Drug Development Process: The process of developing a cancer drug is complex and involves many stages, from preclinical research to clinical trials to regulatory approval. Here is a simplified diagram of the cancer drug development process: Preclinical Research: Researchers identify potential drug candidates and test them in the lab Phase 1 Clinical Trials: Small studies are conducted to test the safety and dosage of the drug in humans Phase 2 Clinical Trials: Larger studies are conducted to test the effectiveness of the drug in treating cancer Phase 3 Clinical Trials: Even larger studies are conducted to compare the new drug to standard treatments and evaluate its safety and effectiveness Regulatory Approval: The drug is reviewed by regulatory agencies such as the FDA and approved for use in the US market o o o o o FDA has developed several approaches to making drugs available as quickly as possible, while still ensuring their safety and effectiveness. Here are four of these approaches: Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat serious conditions and fill an unmet medical need ▪ Fast Track A process designed to expedite the development and review of drugs which may demonstrate substantial improvement over available therapy Breakthrough Therapy ▪ These regulations allowed drugs for serious conditions that filled an unmet medical need to be approved based on a surrogate endpoint Accelerated Approval ▪ Priority Review A Priority Review designation means FDA’s goal is to take action on an application within 6 months ▪ Illustrative Illustrative 19 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  20. 1.6 Healthcare Scenario: Patient Journey Presentation Diagnosis Treatment Follow up Confirmatory Diagnosis Complete blood count (evaluate number & quality of RBCs, Hb & WBCs) Prevention and management of crisis: • For VOC and Splenic Sequestration: HU, Endari, Adakveo, Oxbryta • For infections: Antibiotics, Vaccines • Long term follow-up is required for patients with SCD • Annual assessment: CBC and reticulocyte count, iron status, liver and renal function tests, urinalysis, LDH, vitamin D level and neurocognitive assessment • ESOD (End Stage Organ Damage) evaluation starting from age 7 • Yearly Transcranial Doppler test to determine risk of stroke Initial Diagnosis Imaging (confirm bone related changes or respiratory problems) A suspected diagnosis is usually made, based on physical examination and detailed patient and family history Prenatal screening/ Neonatal screening Bacterial cultures of blood, sputum, urine, stool (detect any infection) Prevention and management of complications: Genetic testing (detect the type of SCD) • Stroke: Chronic transfusions, HU Stakeholders PCP, pediatrician, neonatologist, endocrinologist, cardiologist, hematologist, orthopedist, psychologist and psychiatrist PCP, paediatrician, neonatologist, haematologist and genetic counsellor PCP, pediatrician, medical geneticist, cardiologist, hematologist, endocrinologist, psychologist and psychiatrist PCP, pediatrician, medical geneticist, hematologist, gynecologist and pathologist Depending on the organ complications, the treatment involves different specialists at different times Illustrative Illustrative 20 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  21. 1.7 Health Insurance Coverage: Egypt % of People by Type of Health Insurance Coverage (2021) Number of People By Health Insurance Coverage Coverage Type 2020 2021 Change % 8.3 Uninsured Total 327,521 328,074 91.7 With health insurance Any health plan 299,230 300,887 0.4 Any private plan 217,896 216,366 –0.6 66.0 Any private plan Employment-based 178,737 178,285 –0.2 54.3 Employment-based Direct-purchase 33,869 33,555 –0.1 10.2 Direct-purchase Marketplace coverage 10,924 11,389 0.1 3.5 Marketplace TRICARE 9,165 8,299 –0.3 2.5 TRICARE Any public plan 112,925 117,095 1.2 Medicare 58,541 60,226 0.5 35.7 Any public plan 18.4 Medicare Medicaid 58,778 61,940 0.9 18.9 Medicaid VA and CHAMPVA 2,967 3,151 0.1 1.0 VA and CHAMPVA Uninsured 28,291 27,187 –0.4 In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year More people had private health insurance (66%) than public coverage (35.7%) Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%) ▪ ▪ ▪ Illustrative Illustrative 21 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  22. 1.8 Budget of Egypt Government for Public Insurance Proposed Budget By Category 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31 Outlays $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633 Medicare In Billions Of Dollars $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926 Medicaid 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7% Medicare As % Of GDP 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4% Medicaid National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) ▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE ▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE ▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE ▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE ▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE ▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020 ▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020 ▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020 ▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% ▪ Illustrative Illustrative 22 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  23. 1.9 Mergers and Acquisitions RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend $16.7 112 110 107 107 89 82 $11.7 $10.5 $7.7 $6.8 $6.0 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 Buyer Composition: Strategic Vs Financial (2020) Buyer Type by Deal Size ($Mn) 39% 41% 41% 42% 58% 59% 59% 61% Strategic Buyers Financial Buyers $0- $25 $25-$50 $50-$100 $100+ 57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020 Illustrative Illustrative 23 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  24. 1.9 Mergers and Acquisitions (continued) Latest Deals In Egypt Amount / Duration Company Name Type Year Key Pointers Oracle’s acquisition of Cerner is big tech’s latest foray into the healthcare system, promising better outcomes Oracle acquire Cerner through an all-cash tender offer for $95.00 per share, or approximately $28.3 Bn in equity value Cerner is a leading provider of digital information systems used within hospitals and health systems to enable medical professionals to deliver better healthcare to individual patients and communities ▪ ▪ Acquisition $28.3 Bn June, 2022 ▪ Oracle acquisition of Cerner GSK has acquire BELLUS for US$14.75 per share of common stock in cash representing an approximate total equity value of US$2.0 billion ▪ BELLUS is a late-stage biopharmaceutical company working to better the lives of patients suffering from persistent cough ▪ Acquisition $2 Bn April 2023 Acquisition further strengthens specialty medicines and respiratory pipeline with camlipixant, a highly selective P2X3 antagonist and potential best-in-class treatment for refractory chronic cough ▪ GSK acquisition of BELLUS Health Illustrative Illustrative 24 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  25. 1.9 Mergers and Acquisitions (continued) Latest Deals In Egypt Amount / Duration Company Name Type Year Key Pointers Merger March 2023 Merger Jan 2023 Illustrative Illustrative 25 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  26. Egypt Connected Healthcare Market Analysis 2. Market Size and Forecasting

  27. 2.1 Market size and forecasts (Excel and Methodology) Click on the icon to know the methodology and assumption Egypt Connected Healthcare Market Forecast, 2022-2030 (in $Bn) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ XX XX In this section you will get an understanding of the overall Healthcare Insurance market in Malaysia, which includes the market size, current trends and other details related to the topic ▪ 2022 2023F 2024F 2025F 2026F 2025 2027F 2026 2028F 2027 2029F 2030F 2023 2024 2028 2029 2030 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Major Markets Patient (Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12 Egypt Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative Illustrative ▪ % of US Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45% Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937 Egypt Market Size (Bn $) 61 74 84 87 91 95 99 106 27 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  28. 2.2 Snapshot of Egypt Connected Healthcare Market Segmentation By Type By Function Type By Application Type Remote patient monitoring Diagnosis and Treatment MHealth Services Monitoring Application E- Prescription Clinical monitoring Wellness and Prevention Telemedicine Healthcare management Other In this section you will get an understanding of the segmentations which will cover the Egypt Connected Healthcare Market Analysis ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 28 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  29. 2.2.1 Market Segmentation: By Type Egypt Connected Healthcare Market Share, By Type (2022) E- Prescription market in Egypt is a significant component of the connected healthcare market ▪ It has the maximum market share in Egypt Connected Healthcare market with approximately xx% ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ MHealth Services In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ E- Prescription Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 29 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  30. 2.2.2 Market Segmentation: By Function Type Egypt Connected Healthcare Market Share, By Function Type (2022) Remote Patient Monitoring market in Egypt is a significant component of the overall Connected Healthcare market ▪ It has the maximum market share in Egypt cancer market with approximately xx% ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Telemedicine Remote patient monitoring In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Clinical monitoring Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 30 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  31. 2.2.3 Market Segmentation: By Application Type Egypt Connected Healthcare Market Share, By Application Type (2022) Diagnosis and Treatment Market have the maximum market share in Egypt Connected Healthcare market with approximately xx% ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Wellness and Prevention In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Diagnosis and Treatment Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Monitoring Application 31 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  32. Egypt Connected Healthcare Market Analysis 3. Market Dynamics

  33. 3.1 Market growth drivers 3.1.1 Only about 7.7 Mn Egyptians, or 8.68% of the population, are over 60, but by 2030, these numbers are projected to rise to 18 Mn and 13.8% of the population, respectively. It causes the connected healthcare market in Egypt to grow. There will be a rising need for healthcare connection solutions that are tailored specifically to the needs of the elderly due to the huge increase in the older population. ▪ Population in Egypt This includes telemedicine platforms for remote consultations, wearable technology for tracking one's health, remote patient monitoring systems, and digital health tools that assist in managing chronic diseases. ▪ In order to meet the specific healthcare needs of the ageing population, the Connected Healthcare market can create and extend these solutions. ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 33 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  34. 3.1 Market growth drivers (continued) 3.1.2 With about 15% of adults over 20 having diabetes, 32% being obese, and over 25% having hypertension, Egypt has one of the highest prevalence of lifestyle diseases. It leads to a growth in demand for the Connected Healthcare market in Egypt. Top countries by prevalence of lifestyle diseases A higher emphasis is placed on preventative healthcare, early detection, and efficient management of these problems as a result of the burden of lifestyle diseases. ▪ Norway Austria Denmark In order to increase patient participation, provide real-time health data, facilitate remote consultations, and enable personalized care, healthcare technologies and linked solutions are essential. ▪ Belgium Spain Italy Netherlands Sweden In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Singapore Switzerland Israel Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Australia Canada France United Kingdom China South Korea Germany Japan United States Illustrative Illustrative 34 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  35. 3.2 Market restraints 3.2.1 In 2023, the average cost of a Connected Healthcare Solutions was over $172,000 per year 3.2.2 In Egypt, 54.5% of women received no care, 19.1% of women used the state health system, 26.4% used the private system. It causes limitations on markets for the healthcare-related sector in Egypt. 3.2.3 Demand for Connected Healthcare market in Egypt is expected to increase by 68.24% by 2038, while the source of Connected Healthcare market is only expected to increase by 46.34% In Egypt, healthcare facilities and many consumers may find the expense of connected healthcare solutions, including equipment, software, and services, to be prohibitive, especially for lower- income populations Financial obstacles may be partially to blame for women's limited access to healthcare Healthcare utilization is heavily influenced by affordability, and the high proportion of women who don't receive any treatment shows that many women may have trouble finding cheap healthcare services There is a shortage of Healthcare facilities in Egypt, which can limit access to Connected Healthcare market and create barriers to growth in the Connected Healthcare market With the aging population and the increasing incidence of chronic diseases, there is a growing demand for Healthcare facilities. However, the supply of Healthcare facilities is not keeping pace with the demand ▪ ▪ ▪ ▪ ▪ Healthcare technology accessibility and affordability continue to be problems ▪ ▪ Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. 35 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  36. Egypt Connected Healthcare Market Analysis 4. Competitive Landscape

  37. 4.1 Major Market Share Revenue of Major players in Egypt Connected Healthcare Market ($ Mn) Egypt Connected Healthcare market is a highly competitive space, with many companies developing and marketing cancer treatments ▪ Other Some of the top companies in Egypt Connected Healthcare market based on revenue and market share include ▪ 7Keema is a Swiss multinational healthcare company that develops and markets cancer treatments, including targeted therapies and immunotherapies ▪ In 2020, 7Keema's oncology sales were approximately $24 Bn, making it one of the largest players in Egypt cancer market ▪ XX Illustrative Illustrative 37 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  38. 4.2 Key Company Profile Key Note: 1 7keema Here is the list of top 10 companies which will cover in the final report ▪ 2 Tabibi 24/7 Each company will have slides for ▪ 3 Overview Key details Offerings Name of products Recent activities/ Press Coverage Distribution and Vendor Partners Mergers, Acquisitions and Collaboration Financials If there are specific companies that you would like to be included in the report, please let us know via email In order to obtain access to all of the information that you are seeking, you will need to purchase the final report 3elagi o o 4 Siemens Healthineers o o 5 Allscripts Healthcare o 6 o Apple o 7 Microsoft o 8 Fitbit ▪ 9 McKesson ▪ 10 NXGN Management 38 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  39. 4.2.1 7Keema Solutions offered by 7Keema Founded in: 2017 ▪ Egypt's home nursing services app, 7keema, offers qualified and licensed professional nurses of both sexes to provide safe, prompt, and high-quality services in a broad range of nursing dimensions ▪ It is a platform for healthcare that connects patients with healthcare professionals like physicians, nurses, and physical therapists ▪ Additionally, the portal offers online medical advice and consultations ➢ Diagnostics HQ: Qahirah, Egypt ➢ Child Care Type: Private ➢ Wound Care Revenue: $6.48 Bn ➢ Physiotherapy Website: www.7keema.com ➢ Patient Support Recent Activity / Press Coverage 7keema is named best Egyptian startup at 2021 Seedstars World Competition ▪ Egypt's 7Keema e-health platform was selected as one of the seven winners of Orange Ventures Africa & Gulf East’s 2021 Middle East Startup Challenge. This platform raises the standard and accessibility of nursing services. ▪ The 2020 MEA Seed Challenge of Orange Ventures Africa & Middle East named Egypt's 7Keema e-health platform as one of the seven winners. This platform improves the availability and calibre of nursing services. ▪ 39 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  40. 4.2.1 7Keema (continued) Partnerships Ecosystem Major Distribution Partners Major Vendor Partners One of the largest pharmaceutical distributors in the United States, McKesson has been a long-standing distribution partner for 7Keema 7Keema has been working with SAP, a leading software company, to develop digital solutions for its healthcare products A leading Swiss biotechnology company, Lonza provides 7Keema with contract manufacturing services for the production of its biologics and pharmaceuticals Cardinal Health is a Fortune 500 healthcare services company that provides pharmaceutical distribution services to 7Keema It is one of the largest drugstore chains in the United States and Europe, and its extensive network of retail locations and distribution centers make it an important distribution partner for 7Keema 7Keema has a strategic partnership with Microsoft to leverage its cloud computing and AI technologies in the development of new healthcare products Thermo Fisher Scientific is a leading provider of analytical instruments, reagents, and laboratory services A leading healthcare services provider in Asia, Zuellig Pharma is a distribution partner for 7Keema in several Asian countries GE Healthcare provides 7Keema with advanced medical imaging and diagnostics technologies, including CT scanners and MRI machines Illustrative Illustrative One of the largest pharmaceutical wholesalers in Europe, PHOENIX Group distributes 7Keema's products in several European countries 40 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  41. 4.2.1 7Keema (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers 7Keema and Mynextcare will collaborate on the development of 7Keema Services in the Egypt market ▪ Collaboration - June 2021 Mynextcare 7Keema to acquire Daman Health for $ 4.805 per share with the expectation to close in the 2nd quarter of 2021 ▪ Merger April 2023 Daman Health 41 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  42. 4.2.1 7Keema (continued) Revenues ($Bn), 2020-2030 According to 7Keema's 2020 financial report, the company had sales of CHF 58.3 Bn (Swiss Francs) in 2020 ▪ This is equivalent to approximately $63.3 Bn USD, based on exchange rates at the end of 2020 70.9 ▪ 70.3 63.3 Company's Pharmaceuticals Division generated sales of CHF 49.9 Bn in 2020, while the Diagnostics Division generated sales of CHF 8.4 Bn ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Breakdown of Net Revenue by Segment, 2022 Revenue generated by 7Keema in 2020 reflects the company's continued growth and success in the healthcare industry ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 1 2 3 4 Illustrative Illustrative 42 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  43. 4.2.2 Company 2 Solutions offered by Company Founded in: HQ: Type: Revenue: Website: Drugs for Cancer Recent Activity / Press Coverage Drugs Indications Illustrative Illustrative 43 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  44. 4.2.2 Company 2 (continued) Partnerships Ecosystem Major Distribution Partners Major Vendor Partners Illustrative Illustrative 44 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  45. 4.2.2 Company 2 (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers Illustrative Illustrative 45 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  46. 4.2.2 Company 2 (continued) Revenues ($Bn), 2020-2030 Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ xx xx xx In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Breakdown of Net Revenue by Segment, 2022 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 1 2 3 4 Illustrative Illustrative 46 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  47. Egypt Connected Healthcare Market Analysis 5. Reimbursement Scenario

  48. 5.1 Reimbursement Regulation Medicare and Medicaid together provide health insurance coverage for more than 4 in 10 Americans The reimbursement scenario in the Egypt Connected Healthcare market is complex and can vary depending on the specific treatment, setting of care, and insurance coverage. Here are some key points to consider: Medicare: o ▪ Medicare is a federal health insurance program for people aged 65 and older, as well as people with certain disabilities or health conditions Medicare covers many cancer treatments, including chemotherapy, radiation therapy, and some immunotherapies However, coverage can be subject to strict guidelines and restrictions, such as the requirement for prior authorization Medicaid: o Medicaid is a joint federal-state program that provides health insurance for people with low incomes o Medicaid coverage for cancer treatments can vary by state, and may be subject to limits on the amount and type of treatment covered Private Insurance: o Private insurance coverage for cancer treatments can also vary widely depending on the insurer and the specific policy o Some policies may have high out-of-pocket costs, such as deductibles and co-pays, while others may have more comprehensive coverage Other Public 1% o Other Private 3% Uninsured 9% Medicare 17% o ▪ Medicaid and CHIP 21% ▪ Employer-Sponsored 49% Health Insurance Coverage, 2022 Illustrative Illustrative 48 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  49. 5.1 Reimbursement Regulation (continued) Affordable Care Act: Affordable Care Act (ACA) includes provisions to help improve access to cancer treatments by requiring insurers to cover certain preventive services, including cancer screenings, without co-pays or deductibles It also includes protections for people with pre-existing conditions, such as cancer Reimbursement for New Treatments: Reimbursement for new cancer treatments can be a complex and lengthy process, as insurers and government programs often require evidence of safety and effectiveness before providing coverage This can create challenges for companies developing and marketing new treatments Value-Based Care: There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focusing on the value of treatments rather than simply the volume of treatments Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics ▪ o o ▪ o o ▪ o o In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative Illustrative 49 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

  50. 5.1 Reimbursement Regulation (continued) Coverage Penetration (% Total Population) Source of Funding Spend on Healthcare (%of Current Health Expenditure) 100% 100% 100% 100% 100% 44.0% Government Expenditure 46.0% xx 47.7% xx xx xx 51.0% 51.8% xx Public Healthcare Coverage Private Health Insurance Out of Pocket 38.9% 37.1% 35.6% 31.5% 32.5% Private Coverage Other NA NA 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023  Public healthcare coverage is provided by the government and includes programs like Medicare and Medicaid  Medicare is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities  Medicaid is a joint federal-state program that provides healthcare coverage to individuals with low income and limited resources 6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy) 14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy) Reimbursement Market Trends ▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient outcomes and reducing costs ▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care Illustrative Illustrative 50 A Sample Report on Egypt Connected Healthcare Market Analysis I Confidential

More Related